GNPX · Forms 3, 4, 5

Insider trades at Genprex, Inc.

No open-market insider buys or sells at Genprex, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for Genprex, Inc. (GNPX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Most recent insider filings

No Form 3, 4 or 5 filings for Genprex, Inc. in the last 90 days. The latest ones on EDGAR:

DateInsiderRoleTransactionSharesPriceValueFiling
Brent M LongneckerDirectorSell8$1.23$10Form 4
Brent M LongneckerDirectorSell10$1.23$12Form 4
Mark Stanley BergerChief Medical OfficerTax withholding7,168$2.00$14KForm 4
Ryan M. ConferPresident, CEO and CFOTax withholding9,330$2.00$19KForm 4
Toscano Jose Antonio MorenoDirectorAward9,000Form 4
Mark Stanley BergerChief Medical OfficerAward28,500Form 4
Ryan M. ConferPresident, CEO and CFOAward45,000Form 4
Brent M LongneckerDirectorAward9,000Form 4
William R Wilson Jr.DirectorAward9,000Form 4
Mark Stanley BergerChief Medical OfficerTax withholding4,500$0.23$1KForm 4
Ryan M. ConferPresident, CEO and CFOTax withholding5,775$0.23$1KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.